Therefore, in this review, the IL-4/IL-13 signaling pathways and therapeutic monoclonal antibodies targeting each cytokine or their receptors, as well as dual IL-4/IL-13 blockade, in both AR and asthma are presented and discussed. The gene discussed is IL4; the disease is asthma.